Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMEO6AH)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
Hemado; HEMADO; CHEMBL260563; 403842-38-6; (2R,3R,4S,5R)-2-(2-hex-1-ynyl-6-methylaminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; SCHEMBL935096; GTPL5736; GTPL5599; MolPort-006-822-566; 2-(1-Hexynyl)-N-methyladenosine; 2-(1-Hexynyl)-N6-methyladenosine; ZINC3995955; BDBM50003273; AKOS024456680; HEMADO, >=99% (HPLC), solid
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
||||||||||||||||
|
||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Breast
Breast adenocarcinoma
Colon
Colorectal adenocarcinoma
Hematopoietic system
Normal
Kidney
Normal (Immortalized)
Liver
Hepatoblastoma
Lung
Lung adenocarcinoma
Non-small cell lung carcinoma
Prostate
Prostate carcinoma
Skin
Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
